Prevalence and Localization of Hibernating Myocardium Among Patients with Left Ventricular Dysfunction

Emine Acar1, Ayşegül Aksu2, Gökmen Akkaya3

  • 1Department of Nuclear Medicine, Ataturk Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey.

Insights

Myocardial viability studies reveal that perfusion defects in patients with left ventricle dysfunction are equally divided between hibernating and scar tissue. Scar tissue is more prevalent in the left anterior descending artery territory, while hibernation is most common in the right coronary artery territory.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Cardiac Imaging

Background:

  • Left ventricle dysfunction often necessitates revascularization procedures.
  • Assessing myocardial viability is crucial for guiding treatment decisions in such patients.
  • Comorbidities can influence the complexity of managing left ventricle dysfunction.

Purpose of the Study:

  • To quantify hibernating myocardium in patients with left ventricle dysfunction undergoing revascularization.
  • To identify coronary artery territories with higher scar or hibernating tissue burden.
  • To correlate imaging findings with planned surgical or interventional revascularization.

Main Methods:

  • Retrospective analysis of 65 patients (March 2009 - September 2016).
  • Utilized rest technetium-99m sestamibi (Tc-99m MIBI) SPECT and fluorine-18 fluorodeoxyglucose (F-18 FDG) PET/CT.
  • Defined hibernating myocardium as metabolically active areas with perfusion defects; scar as non-metabolic areas with perfusion defects.

Main Results:

  • Perfusion defects were present in 26% of the myocardium.
  • These defects were composed of approximately 48% hibernating tissue and 52% scar tissue.
  • Defects were most common in the left anterior descending (LAD) artery territory (31%), followed by the right coronary artery (RCA; 23%) and left circumflex artery (LCx; 19%).
  • Hibernation was most prevalent in RCA (64%) and LCx (54%) territories, while scar tissue was more common in the LAD (54%) territory.

Conclusions:

  • Perfusion defects in this cohort represent a near equal mix of hibernating and scar tissue.
  • The LAD territory showed the highest overall perfusion defects, predominantly scar.
  • The RCA territory exhibited the highest proportion of hibernating myocardium.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
427
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
385
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
253
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
287
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
380